Table 6 Univariate and multivariate analysis for patient with high-risk factors
Variable | High-risk (No. %) | Univariate | Multivariate | |||
|---|---|---|---|---|---|---|
No | Yes | p value | OR | 95% CI | p value | |
Age (year) | 0.580 | |||||
< 50.5 | 96 (40.5%) | 50 (21.1%) | ||||
≥ 50.5 | 63 (26.6%) | 28 (11.8%) | ||||
SCCA (ng/ml) | < 0.001 | 3.282 | 1.675–6.430 | 0.001 | ||
< 2.45 | 95 (41.3%) | 18 (7.8%) | ||||
≥ 2.45 | 62 (27.0%) | 55 (23.9%) | ||||
FIGO stage | 0.233 | |||||
IA2-IB2 | 70 (29.5%) | 28 (11.8%) | ||||
IIA1-IIA2 | 89 (37.6%) | 50 (21.1%) | ||||
SUVmax | 0.116 | |||||
< 7.96 | 36 (15.3%) | 11 (4.7%) | ||||
≥ 7.96 | 122 (51.7%) | 67 (28.4%) | ||||
MTV | < 0.001 | 2.749 | 1.230–6.143 | 0.014 | ||
< 20.88 | 66 (28.1%) | 11 (4.7%) | ||||
≥ 20.88 | 91 (38.7%) | 67 (28.5%) | ||||
TLG | < 0.001 | – | – | 0.893 | ||
< 137.40 | 81 (34.5%) | 20 (8.5%) | ||||
≥ 137.40 | 76 (32.3%) | 58 (24.7%) | ||||